Development of Posttraumatic Stress Disorder During Treatment of Depression With Lamotrigine

References (6)

1. Besag FMC, Vasey MJ, Sharma AN, et al. Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Ther Adv Psychopharmacol. 2021;11:20451253211045870. PubMed CrossRef
2. Goh KK, Chen CH, Chiu YH, et al. Lamotrigine augmentation in treatment-resistant unipolar depression: a comprehensive meta-analysis of efficacy and safety. J Psychopharmacol. 2019;33(6):700–713. PubMed CrossRef
3. de Moraes Costa G, Zanatta FB, Ziegelmann PK, et al. Pharmacological treatments for adults with post-traumatic stress disorder: a network meta-analysis of comparative efficacy and acceptability. J Psychiatr Res. 2020;130:412–420. PubMed CrossRef
4. Kim SJ, Lee SA, Ryu HU, et al. Factors associated with obsessive-compulsive symptoms in people with epilepsy. Epilepsy Behav. 2020;102:106723. PubMed CrossRef
5. Sharma V, Doobay M. Lamotrigine-induced obsessive-compulsive disorder in patients with bipolar disorder. CNS Spectr. 2019;24(4):390–394. PubMed CrossRef
6. Thakur GS, Daigle BJ Jr, Dean KR, et al. Systems biology approach to understanding post-traumatic stress disorder. Mol Biosyst. 2015;11(4):980–993. PubMed CrossRef